Multidrug-resistant tuberculosis

Saudi Medical Journal

Volumn 19, Issue 6, 1998, Pages 802-806

  Wali, Siraj ^a   Samman, Yassin ^a   Osoba, Abimbola O ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Control; Multidrug resistant mycobacterium tuberculosis; Treatment

Indexed keywords

BACTERIAL DNA; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; FEMALE; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 0031762594     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Iseman MD. Treatment of multidrug-resistant Tuberculosis. NEJM. 1993; 329 (11): 784-791.
2. Hyman CL, Kamholz SL. The approach to Multiple-Drug-Resistant Tuberculosis. Pulmonary Critical Care Update. 1993; 9(11): 2-6.
3. Vareldzis BP, Grosset J, de Kantor I, Crofton J, Laszlo A, Feiten M, Raviglione MC, Kochi A. Drug-resistant tuberculosis: Laboratory issues. World Health Organization recommendations. Tubercle and Lung Disease. 1994, 75; 16.
4. Kelleher P, Coakley J, Anderson J, Moore-Gillon J. Multidrug-resistant Tuberculosis in an HIV-positive Man in the United Kingdom. Journal of Infection. 1996; 32 : 153-154.
5. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. JAMA 1993; 270: 65-68.
6. Obnicwski FA, Yates MD. Editorial: Multiple drug resistant tuberculosis. J. Clin. Pathol. 1997; 50: 89-92
7. Ellis ME, Al-Hajjar S, Bokhari H, Qadri SH. High Proportion of Multi-drug Resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis 1996; 28: 591-595.
8. Al-Kassimi FA. Review of Tuberculosis in Saudi Arabia Saudi Med J. 1994: 15(3): 192-195.
9. Cole ST. Mycobacterium tuberculosis: drug-resistance mechanisms. Trends in Microbiology- 1994; 2(10): 411-415.
10. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993; 328: 527-532.
11. Weis SE, Slocum PC, Biais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J MED 1994; 330: 1179-1184.
12. MMWR. Initial therapy for tuberculosis in the era of multidrug resistance: Recommendations of the advisory council for the elimination of tuberculosis. JAMA 1993; 270: 694-698.
13. WHO. Guidelines on the management of Drug-Resistant Tuberculosis. Crofton J, Chaulet P, Moker D. WHO/ TB.96.210
14. American Thoracic Society : Diagnosis and of Disease caused by nontuberculous Mycobacteria. AMJ Respir Crit Care Med 1997; 156: S1-S25.
15. Schiott Cr, Engbaek HC, Vergmann B, Al-Motez M, Kassim I. Incidence of drug resistance among isolates of Mycobacterium tuberculosis recoved in the Gizan area, Saudi Arabia. Saudi Medical Journal. 1985; 6(4): 375-378.
16. Al-Orainey (1), Saeed ES, El-Kassimi A, Al-Shareef N. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia, Tubercule. 1989; 70: 207-210.
17. Jarallah JS, Eliias AK, Al-Hajjaj MS, Bulhari MS, Al-Shareef HM, Al-Shamman SA. High rate of Rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle and Lung Disease. 1992; 73: 113-115.
18. Dooley SW, Jarvis WR, Martone WJ, Snider DE. Multidrug-resistant Tuberculosis (Editorial). Annals of Internal Medicine. 1992; 117(3): 257-259.